Related Experiment Video
Updated: Jul 19, 2026

Isolation of Whole Cell Protein Lysates from Mouse Facial Processes and Cultured Palatal Mesenchyme Cells for Phosphoprotein Analysis
Published on: April 1, 2022
Molecular determinants of FGF-21 activity-synergy and cross-talk with PPARgamma signaling
Julie S Moyers1, Tatiyana L Shiyanova, Farrokh Mehrbod
1Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, USA.
Abstract:
Fibroblast growth factor (FGF)-21 is a novel regulator of insulin-independent glucose transport in 3T3-L1 adipocytes and has glucose and triglyceride lowering effects in rodent models of diabetes. The precise mechanisms whereby FGF-21 regulates metabolism remain to be determined. Here we describe the early signaling events triggered by FGF-21 treatment of 3T3-L1 adipocytes and reveal a functional interplay between FGF-21 and peroxisome proliferator-activated receptor gamma (PPARgamma) pathways that leads to a marked stimulation of glucose transport. While the early actions of FGF-21 on 3T3-L1 adipocytes involve rapid accumulation of intracellular calcium and phosphorylation of Akt, GSK-3, p70(S6K), SHP-2, MEK1/2, and Stat3, continuous treatment for 72 h induces an increase in PPARgamma protein expression. Moreover, chronic activation of the PPARgamma pathway in 3T3-L1 adipocytes with the PPARgamma agonist and anti-diabetic agent, rosiglitazone (BRL 49653), enhances FGF-21 action to induce tyrosine phosphorylation of FGF receptor-2. Strikingly, treatment of cells with FGF-21 and rosiglitazone in combination leads to a pronounced increase in expression of the GLUT1 glucose transporter and a marked synergy in stimulation of glucose transport. Together these results reveal a novel synergy between two regulators of glucose homeostasis, FGF-21 and PPARgamma, and further define FGF-21 mechanism of action.
Insights
Fibroblast growth factor (FGF)-21 and peroxisome proliferator-activated receptor gamma (PPARgamma) synergize to enhance glucose transport in adipocytes. This study defines novel mechanisms for FGF-21 in glucose homeostasis.
Area of Science:
- Metabolic research
- Cell signaling
- Diabetes research
Background:
- Fibroblast growth factor (FGF)-21 regulates glucose transport independently of insulin.
- FGF-21 demonstrates glucose and triglyceride-lowering effects in diabetic rodent models.
- The precise metabolic regulatory mechanisms of FGF-21 require further elucidation.
Purpose of the Study:
- To investigate the early signaling events triggered by FGF-21 in 3T3-L1 adipocytes.
- To explore the interplay between FGF-21 and peroxisome proliferator-activated receptor gamma (PPARgamma) pathways.
- To elucidate the synergistic effects on glucose transport.
Main Methods:
- Treatment of 3T3-L1 adipocytes with FGF-21.
- Analysis of intracellular calcium accumulation and protein phosphorylation (Akt, GSK-3, p70(S6K), SHP-2, MEK1/2, Stat3).
- Assessment of PPARgamma protein expression and GLUT1 glucose transporter levels following chronic treatment and combination therapy with rosiglitazone.
Main Results:
- FGF-21 treatment induced rapid intracellular calcium accumulation and phosphorylation of key signaling proteins.
- Continuous FGF-21 exposure elevated PPARgamma protein expression.
- Combined FGF-21 and rosiglitazone treatment synergistically increased GLUT1 expression and glucose transport.
Conclusions:
- A novel synergy exists between FGF-21 and PPARgamma pathways in regulating glucose homeostasis.
- FGF-21's mechanism of action involves interplay with PPARgamma signaling.
- These findings offer new insights into FGF-21's role in metabolic regulation and potential therapeutic strategies for diabetes.
Related Concept Videos
TGF - β Signaling Pathway
Hedgehog Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Master Transcription Regulators
Regulation of Angiogenesis and Blood Supply
General Transcription Factors

